SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-046174
Filing Date
2021-04-02
Accepted
2021-04-02 17:26:42
Documents
5
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212332-1_def14a.htm DEF 14A 606647
2 GRAPHIC lg_innoviva-bw.jpg GRAPHIC 13063
3 GRAPHIC sg_pavelraifeld-bw.jpg GRAPHIC 14220
4 GRAPHIC tm212332d1-pc_noticebw.jpg GRAPHIC 439668
5 GRAPHIC tm212332d1-pc_votebw.jpg GRAPHIC 495642
  Complete submission text file 0001104659-21-046174.txt   1933988
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 21803040
SIC: 2834 Pharmaceutical Preparations